Meeting
2023 ASCO Genitourinary Cancers Symposium
Clinical characteristics and outcomes of SARS-CoV-2 infection in patients with genitourinary cancer.
Authors
Dorothy Kenny
Creighton University School of Medicine-Phoenix, Phoenix, AZ
Dorothy Kenny , Jue Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 7)
DOI
10.1200/JCO.2023.41.6_suppl.7
Abstract #
7
Poster Bd #
D12
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
The effect of corticosteroid on immunogenicity of SARS-CoV-2 vaccines in solid cancer patients.
First Author: Chayanee Samdaengpan
Poster
2023 ASCO Genitourinary Cancers Symposium
COVID-19 vaccines in patients with urothelial cancers receiving immune checkpoint inhibitors.
First Author: Danielle Gilbert
Poster
2022 ASCO Annual Meeting
Patient-reported toxicity and quality of life following Sars-CoV-2 vaccination in adults and children with cancer.
First Author: Amy Body
Poster
2022 ASCO Genitourinary Cancers Symposium
Waning efficacy of COVID-19 vaccination at six months in patients (pts) with genitourinary malignancies.
First Author: Zeynep Busra Zengin